SACUBITRIL-VALSARTAN 97-103 MG

What it is

SACUBITRIL-VALSARTAN 97-103 MG is how the CMS NADAC file names this product. The FDA NDC Directory lists it as sacubitril and valsartan, under the trade name “Sacubitril and Valsartan Sacubitril and Valsartan”.

FDA gives its dosage form as “tablet, film coated” and “tablet” and its route as oral.

FDA lists 16 labelers (the companies named on the label) for its NDCs, among them Major Pharmaceuticals, Torrent Pharmaceuticals Limited and Camber Pharmaceuticals, Inc.

FDA lists it under 2 Established Pharmacologic Classes: Angiotensin 2 Receptor Blocker and Neprilysin Inhibitor.

The NADAC file of 2026-10-14 prices it under 32 NDCs (National Drug Codes); the FDA directory lists 30 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $17.76 for 30 tablets (30 × $0.59213 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

What NADAC measures · Why 30 tablets · NADAC explanation codes

The 16 labelers

Other strengths, forms and brands

7 other products in the NADAC file share the FDA nonproprietary name sacubitril and valsartan with SACUBITRIL-VALSARTAN 97-103 MG.

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 32 NDCs’ NADAC prices is $0.59213 per EA filed.

Of the 107 other products in FDA’s Angiotensin 2 Receptor Blocker class priced per EA, 61 have a higher middle NADAC price and 46 a lower one. The one in the middle is OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5, at $1.15137 per EA filed (eff. 2026-09-23).

Of the 7 other products in FDA’s Neprilysin Inhibitor class priced per EA, 5 have a higher middle NADAC price and 2 a lower one. The one in the middle is ENTRESTO 97 MG-103 MG TABLET, at $11.58867 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

How the class comparison works

What Medicare paid

We don’t know yet; the card above says why.

Which Medicare figure OpenBill compares · How Part D is matched · How Part B is matched

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

• What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
• These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.